Cbd Life Sciences
(OTC) CBDL
Cbd Life Sciences Financials at a Glance
Market Cap
$1.14M
Revenue (TTM)
$71.05K
Net Income (TTM)
$643.33K
EPS (TTM)
$-0.00
P/E Ratio
-0.50
Dividend
$0.00
Beta (Volatility)
-78.71 (Low)
Dividend
$0.00
Beta (Volatility)
-78.71 (Low)
Price
$0.00
Volume
32,228,635
Open
$0.00
Price
$0.00
Volume
32,228,635
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-78.71 (Low)
Price
$0.00
Volume
32,228,635
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
CBDL News
CBDL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cbd Life Sciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
4
CEO
Lisa Nelson
Website
cre8tive.worksHeadquarters
Scottsdale, AZ 85259, US
CBDL Financials
Key Financial Metrics (TTM)
Gross Margin
-10%
Operating Margin
-10%
Net Income Margin
-9%
Return on Equity
-191%
Return on Capital
-92%
Return on Assets
-80%
Earnings Yield
-2.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.14M
Shares Outstanding
5.70B
Volume
32.23M
Short Interest
0.00%
Avg. Volume
9.39M
Financials (TTM)
Gross Profit
$41.49K
Operating Income
$101.70K
EBITDA
$101.70K
Operating Cash Flow
$139.15K
Capital Expenditure
$0.00
Free Cash Flow
$139.15K
Cash & ST Invst.
$331.60K
Total Debt
$0.00
Cbd Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$28.24K
-28.0%
Gross Profit
$11.81K
-25.0%
Gross Margin
41.82%
N/A
Market Cap
$1.14M
N/A
Market Cap/Employee
$379.80K
N/A
Employees
3
N/A
Net Income
$31.55K
+146.7%
EBITDA
$26.80K
+45.3%
Quarterly Fundamentals
Net Cash
$331.60K
+1791.3%
Accounts Receivable
$215.69K
+5.5%
Inventory
$35.08K
+240.6%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-79.89%
N/A
Return on Invested Capital
-91.52%
N/A
Free Cash Flow
$46.01K
+3968.1%
Operating Cash Flow
$46.01K
+3967.8%